Giraffe Bio raises $6.4M for biomolecule-based copper extraction

Giraffe Bio, a biotechnology company, has raised $6.4 million in seed funding to develop novel approaches to copper extraction. This capital infusion addresses the escalating global demand for copper, driven by the proliferation of AI data centers and electric vehicles.

Industry forecasts predict a potential shortfall of up to 25% in copper supply by 2040 compared to demand. Historically, the mining sector has responded to increased demand by opening new mines, a process that is both costly and uncertain, with a very low success rate for new prospects.

Giraffe Bio's strategy focuses on creating bespoke biomolecules designed to enhance the efficiency of copper separation from existing ore deposits. This approach aims to reduce reliance on developing new mining operations, which are often expensive and have significant environmental implications.

The company's technology leverages biological and chemical processes to create more effective and potentially more sustainable extraction methods. This funding will enable Giraffe Bio to advance its research and development efforts and prepare for the commercial deployment of its technology in the global minerals market.